Press Releases

News Brief

Samsung Biologics attends 2023 CDMO Leadership Awards Ceremony

Samsung Biologics attends 2023 CDMO Leadership Awards Ceremony

Samsung Biologics attended the 2023 CDMO Leadership Awards ceremony in New York to receive the Champion Award in four categories - capabilities, compatibility, reliability, and quality - and the Excellence Award in all six categories. Kevin Sharp, VP and Head of Samsung Biologics America Sales, received the award on behalf of the company.

 

Now in its 12th year, the CDMO Leadership Awards offer accurate and reliable customer feedback to provide support in choosing a reputable partner for development and manufacturing needs within the biopharmaceutical and pharmaceutical industry. Since 2013, Samsung Biologics has been recognized in the CDMO Leadership Awards for ten consecutive years.

Samsung Biologics attends 2023 CDMO Leadership Awards Ceremony

Samsung Biologics attended the 2023 CDMO Leadership Awards ceremony in New York to receive the Champion Award in four categories - capabilities, compatibility, reliability, and quality - and the Excellence Award in all six categories. Kevin Sharp, VP and Head of Samsung Biologics America Sales, received the award on behalf of the company.

 

Now in its 12th year, the CDMO Leadership Awards offer accurate and reliable customer feedback to provide support in choosing a reputable partner for development and manufacturing needs within the biopharmaceutical and pharmaceutical industry. Since 2013, Samsung Biologics has been recognized in the CDMO Leadership Awards for ten consecutive years.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION